The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of vemurafenib and heat shock protein 90 (HSP90) inhibitor XL888 in metastatic BRAF V600 mutant melanoma.
 
Zeynep Eroglu
No Relationships to Disclose
 
Geoffrey Thomas Gibney
Honoraria - Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Novartis
 
Jeffrey S. Weber
Stock and Other Ownership Interests - Altor BioScience; Celldex; Merck
Honoraria - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Consulting or Advisory Role - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Genentech; GlaxoSmithKline; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
 
Ragini Reiney Kudchadkar
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech
Research Funding - Merck
 
Nikhil I. Khushalani
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Castle Biosciences
Speakers' Bureau - Prometheus
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Merck (Inst); NCCN (Inst); Novartis (Inst); Pfizer (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst)
 
Joseph Markowitz
Research Funding - Macrogenics (Inst); Reata Pharmaceuticals (Inst)
 
Leticia F. Tetteh
No Relationships to Disclose
 
Howida Ramadan
No Relationships to Disclose
 
Xiuhua Zhao
No Relationships to Disclose
 
Ann Chen
No Relationships to Disclose
 
Ritin Sharma
No Relationships to Disclose
 
Jane Messina
No Relationships to Disclose
 
John M Koomen
No Relationships to Disclose
 
Vernon K. Sondak
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck/Schering Plough; Novartis; Provectus
 
Keiran Smalley
Research Funding - FORMA Therapeutics (Inst)